Search
Patexia Research
Case number 1:21-cv-01621

Gilead Sciences, Inc. et al v. Lupin Limited et al > Documents

Date Field Doc. No.Description (Pages)
May 16, 2024 211 NOTICE requesting Clerk to remove Jeffrey Coleman, Hannah Lee, Jonathan R. Pepin, Marcus A. Colucci, and the law firm of KRAMER LEVIN NAFTALIS & FRANKEL LLP as co-counsel.. (Tigan, Jeremy) (Entered: 05/16/2024) (3)
Apr 30, 2024 210 NOTICE of Change of Firm Affiliation for Daniel Williams and Christine Willgoos by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 04/30/2024) (4)
Apr 29, 2024 208 MOTION for Pro Hac Vice Appearance of Attorney Raghav Krishnapriyan, Michael Scerbo and Ernest Fok - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/29/2024) (7)
Apr 29, 2024 209 Pro Hac Vice Fee - Credit Card Payment received for Raghav Krishnapriyan, Michael Scerbo, and Ernest Fok. ( re 208 MOTION for Pro Hac Vice Appearance of Attorney Raghav Krishnapriyan, Michael Scerbo and Ernest Fok )( Payment of $ 150, receipt number ADEDC-4395160).(Tigan, Jeremy) (Entered: 04/29/2024) (0)
Apr 15, 2024 207 NOTICE of Change of Firm Affiliation by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 04/15/2024) (4)
Apr 1, 2024 206 REDACTED VERSION of 205 Letter by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/01/2024) (2)
Mar 26, 2024 204 REDACTED VERSION of 201 Letter, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 03/26/2024) (2)
Mar 26, 2024 205 [SEALED] Joint Letter to The Honorable Maryellen Noreika from the Parties regarding Trial. (Tigan, Jeremy) (Entered: 03/26/2024) (0)
Mar 19, 2024 202 Letter to The Honorable Maryellen Noreika from John C. Phillips, Jr. regarding scheduling trial. (Phillips, John) (Entered: 03/19/2024) (1)
Mar 19, 2024 203 ORAL ORDER Setting Teleconference re Letters ( 201 , 202 ): A Telephone Conference is set for 3/20/2024 at 03:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's Courtroom Deputy (Mark_Buckson@ded.uscourts.gov). ORDERED by Judge Maryellen Noreika on 3/19/2024. (mdb) (Entered: 03/19/2024) (0)
Mar 18, 2024 201 [SEALED] Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Hearing on Lupin's Motion to Dismiss for Failure to State a Claim and Motion for Clarification - re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61, 200 Order Setting Hearing on Motion,,,. (Tigan, Jeremy) Modified on 3/19/2024 (mdb). (Entered: 03/18/2024) (0)
Mar 13, 2024 200 ORAL ORDER Setting Hearing on 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 - IT IS HEREBY ORDERED that a Motion Hearing is set for 3/26/2024 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. The Court is setting aside 30 minutes for the argument with the time split equally between the parties. Any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing with hard copies delivered to the Clerk's Office within 1 hour thereafter. The parties may, however, agree upon a different time to exchange their respective slides. ORDERED by Judge Maryellen Noreika on 3/13/2024. (dlw) (Entered: 03/13/2024) (0)
Feb 9, 2024 199 SO ORDERED re 198 Stipulation and Order to Amend Scheduling Order (pretrial order exchange deadlines; motion in limine deadlines). Signed by Judge Maryellen Noreika on 2/9/2024. (dlw) (Entered: 02/09/2024) (3)
Feb 8, 2024 198 STIPULATION and [Proposed] Order to Amend Scheduling Order re 123 SO ORDERED,,, Set/Reset Scheduling Order Deadlines,, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 02/08/2024) (3)
Jan 30, 2024 196 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Richard T. Ruzich - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 01/30/2024) (4)
Jan 30, 2024 197 Pro Hac Vice Fee - Credit Card Payment received for Andrew M. Alul and Richard T. Ruzich. ( re 196 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Richard T. Ruzich )( Payment of $ 100, receipt number ADEDC-4326091).(Dorsney, Kenneth) (Entered: 01/30/2024) (0)
Jan 24, 2024 194 Letter to The Honorable Colm F. Connolly and The Honorable Maryellen Noreika from Kelly Farnan and John C. Phillips, Jr. regarding trial conflict. (Phillips, John) (Entered: 01/24/2024) (2)
Jan 24, 2024 195 ORAL ORDER re 194 Letter - Having reviewed the parties' letter and having discussed the issue with Chief Judge Connolly, IT IS HEREBY ORDERED that the trial in this matter shall be RESET to begin on 6/24/2024. The Pretrial Conference is RESET for 6/17/2024 at 4:30 PM (Set/Reset Scheduling Order Deadlines: A Pretrial Conference is set for 6/17/2024 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/24/2024 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika). ORDERED by Judge Maryellen Noreika on 1/24/2024. (dlw) (Entered: 01/24/2024) (0)
Jan 18, 2024 193 NOTICE to Take Deposition of Daniel R. Kuritzkes, M.D. on January 26, 2024 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/18/2024) (2)
Dec 27, 2023 192 STIPULATION TO EXTEND TIME for the completion of expert discovery to January 26, 2024 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 12/27/2023) (2)
Dec 19, 2023 190 NOTICE to Take Deposition of Dr. Graham Buckton on December 21, 2023 and January 16, 2024 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/19/2023) (5)
Dec 19, 2023 191 NOTICE to Take Deposition of Dr. Chloe Thio on January 10, 2024 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/19/2023) (5)
Dec 13, 2023 189 Supplemental Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Gilead Sciences, Inc.; Corporate Parent Gilead Sciences, Inc. for Gilead Sciences Ireland UC filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 12/13/2023) (4)
Dec 1, 2023 186 NOTICE to Take Deposition of Robert O. Williams, III, Ph.D. on December 14, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2)
Dec 1, 2023 187 NOTICE to Take Deposition of Leah Appel, Ph.D. on December 8, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2)
Dec 1, 2023 188 NOTICE to Take Deposition of Greg Bell, Ph.D. on December 7, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2)
Nov 29, 2023 185 MOTION for Pro Hac Vice Appearance of Attorney Jeremiah S. Helm - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jeremiah S. Helm)(Bilson, David) (Entered: 11/29/2023) (0)
Nov 27, 2023 184 NOTICE OF SERVICE of (1) [CONFIDENTIAL] Reply Expert Report of Graham Buckton Regarding Invalidity of US Patent 10,039,718; (2) [CONFIDENTIAL] Reply Expert Report of Graham Buckton Regarding Secondary Considerations Concerning US Patent 10,786,518; and (3) [CONFIDENTIAL] Reply Expert Report of Dr. Chloe Thio Regarding Invalidity of US Patent 10,786,518 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 11/27/2023) (2)
Nov 22, 2023 183 NOTICE OF SERVICE of (1) Reply Expert Report of Leah Appel, Ph.D., Regarding US. 10,039,718; (2) Reply Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. 10,786,518; (3) Reply Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Infringement of U.S. Patent No. 10,786,518 and Objective Indicia of Non-Obviousness; and (4) Reply Report of Gregory K. Bell, PhD. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/22/2023) (6)
Nov 16, 2023 182 ORAL ORDER - IT IS HEREBY ORDERED that the parties shall engage in in-person mediation in good faith. The parties are to jointly hire an agreed-upon mediator. The timing of mediation efforts is left to the discretion of the parties, but the mediation must be conducted in advance of the pretrial conference. No later than one week before the pretrial conference, the parties shall submit a joint statement that identifies the mediator, the lead counsel for each party at the mediation and the length of the mediation, as well as a certification by the lead counsel that they have engaged in the mediation efforts in good faith. The joint statement should not disclose the substance of any offers, counteroffers or other negotiations. If the parties anticipate any further mediation efforts will be conducted after the deadline to submit the joint statement, the parties shall indicate that in their submission and state when those efforts are expected to occur. ORDERED by Judge Maryellen Noreika on 11/16/2023. (dlw) (Entered: 11/16/2023) (0)
Oct 20, 2023 181 NOTICE OF SERVICE of [CONFIDENTIAL] Rebuttal Report of Graham Buckton Regarding Secondary Considerations of US Patent 10,039,718; [CONFIDENTIAL] Rebuttal Report of Graham Buckton Regarding Secondary Considerations of US Patent 10,786,518; [CONFIDENTIAL] Rebuttal Expert Report of Ivan Hofmann; and [CONFIDENTIAL] Responsive Expert Report of Dr. Chloe Thio Regarding Alleged Infringement and Secondary Considerations of US Patent 10,786,518 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 10/20/2023) (2)
Oct 19, 2023 180 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Leah Appel, Ph.D., Regarding U.S. 10,039,718; (2) Rebuttal Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Validity of U.S. Patent No. 10,786,518; and (3) Rebuttal Expert Report of Robert O. Williams III, Ph.D., Regarding the Validity of U.S. Patent No. 10,786,518 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 10/19/2023) (6)
Oct 10, 2023 179 ANSWER to 163 Answer to Complaint, Counterclaim by Gilead Sciences, Inc..(Tigan, Jeremy) (Entered: 10/10/2023) (6)
Oct 9, 2023 175 REDACTED VERSION of 172 Reply Brief, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 10/09/2023) (0)
Oct 9, 2023 176 REDACTED VERSION of 173 Declaration, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 15-17, # 2 Certificate of Service)(Phillips, John) (Entered: 10/09/2023) (0)
Oct 9, 2023 177 REDACTED VERSION of 168 Answering Brief in Opposition, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/09/2023) (28)
Oct 9, 2023 178 REDACTED VERSION of 169 Declaration, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # 1 Ex. 1, # 2 Ex. 2, # 3 Ex. 3, # 4 Ex. 4)(Tigan, Jeremy) (Entered: 10/09/2023) (0)
Oct 5, 2023 174 REQUEST for Oral Argument by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61. (Phillips, John) (Entered: 10/05/2023) (2)
Oct 2, 2023 171 STIPULATION TO EXTEND TIME for Plaintiffs to file redacted versions of their Answering Brief in Opposition to Defendants' Motion to Dismiss (D.I. 168) and Declaration in Support of their Answering Brief in Opposition to Defendants' Motion to Dismiss (D.I. 169) to October 9, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/02/2023) (2)
Oct 2, 2023 172 [SEALED] REPLY BRIEF re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 10/02/2023) (0)
Oct 2, 2023 173 [SEALED] Supplemental DECLARATION of Jonathan Bachand re 172 Reply Brief by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. (Attachments: # 1 Exhibits 15-17, # 2 Certificate of Service)(Phillips, John) Modified on 10/3/2023 (dlw). (Entered: 10/02/2023) (0)
Sep 26, 2023 170 STIPULATION TO EXTEND TIME for: (1) Rebuttal Expert Reports to October 19, 2023; (2) Reply Expert Reports to November 22, 2023; and (3) Completion of Expert Discovery to January 5, 2024 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 09/26/2023) (2)
Sep 25, 2023 168 [SEALED] ANSWERING BRIEF in Opposition re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.Reply Brief due date per Local Rules is 10/2/2023. (Tigan, Jeremy) (Entered: 09/25/2023) (0)
Sep 25, 2023 169 [SEALED] DECLARATION of Marcus A. Colucci re 168 Answering Brief in Opposition by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Tigan, Jeremy) Modified on 9/26/2023 (dlw). (Entered: 09/25/2023) (0)
Sep 22, 2023 166 ANSWER to Complaint // MSN's Answer regarding C.A. No. 23-774 Complaint by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. (Hitch, Cortlan) Modified on 9/25/2023 (dlw). (Entered: 09/22/2023) (29)
Sep 22, 2023 167 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Pharmaceuticals, Inc. for MSN Laboratories Private Ltd. filed by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 09/22/2023) (2)
Sep 20, 2023 165 MOTION for Pro Hac Vice Appearance of Attorney Christine Willgoos - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 09/20/2023) (5)
Sep 18, 2023 163 ANSWER to 1 Complaint, COUNTERCLAIM // regarding C.A. No. 23-774 Complaint against Gilead Sciences Ireland UC by Apotex Inc., Apotex Corp. (Hitch, Cortlan) Modified on 9/19/2023 (dlw). (Entered: 09/18/2023) (30)
Sep 18, 2023 164 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 09/18/2023) (1)
Aug 29, 2023 160 REDACTED VERSION of 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order, # 2 Proposed Order, # 3 Certificate of Service)(Phillips, John) (Entered: 08/29/2023) (0)
Aug 29, 2023 161 REDACTED VERSION of 155 Opening Brief in Support, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 08/29/2023) (0)
Aug 29, 2023 162 REDACTED VERSION of 156 Declaration, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-14)(Phillips, John) (Entered: 08/29/2023) (0)
Aug 25, 2023 159 STIPULATION TO EXTEND TIME for Defendants to file redacted versions of their Motion for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief from D.I. 61 and supporting documents to August 29, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/25/2023) (2)
Aug 24, 2023 158 STIPULATION TO EXTEND TIME for Plaintiffs to file their opposition to Defendants' Motion to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief from D.I. 61 (D.I. 153) to September 22, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/24/2023) (2)
Aug 21, 2023 157 NOTICE OF SERVICE of Plaintiff Gilead Sciences, Inc's Initial Rule 26 Disclosures - filed by Gilead Sciences, Inc..(Tigan, Jeremy) (Entered: 08/21/2023) (6)
Aug 18, 2023 153 [SEALED] MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Text of Proposed Order, # 3 Certificate of Service)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0)
Aug 18, 2023 154 NOTICE OF SERVICE of (1) Apotex and MSN's Initial 26(a) Disclosures and; (2) Apotex and MSN's Paragraph 3 Disclosures filed by Apotex Corp., Apotex Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Main Document 154 replaced on 8/21/2023) (dlw). (Main Document 154 replaced on 8/21/2023) (dlw). (Entered: 08/18/2023) (3)
Aug 18, 2023 155 [SEALED] OPENING BRIEF in Support re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. Answering Brief/Response due date per Local Rules is 9/1/2023. (Attachments: # 1 Certificate of Service)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0)
Aug 18, 2023 156 [SEALED] DECLARATION of Jonathan E. Bachand re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-11, # 3 Exhibit 12-14)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0)
Aug 14, 2023 152 SO ORDERED re (151 in 1:21-cv-01621-MN, 12 in 1:23-cv-00774-MN) Stipulation and Order of Infringement and Consolidation. Signed by Judge Maryellen Noreika on 8/14/2023. (dlw) (dlw). (Entered: 08/14/2023) (6)
Aug 11, 2023 151 STIPULATION of Infringement and Consolidation and [Proposed] Order by Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/11/2023) (6)
Aug 10, 2023 149 NOTICE OF SERVICE of (1) Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Infringement of U.S. Patent No. 10,786,518 and Objective Indicia of Non-obviousness, (2) Opening Expert Report of Robert O. Williams, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. 10,786,518, (3) Expert Report of Gregory K. Bell, PhD,, (4) Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding U.S. Patent No. 10,039,718, (5) Opening Expert Report of Leah Appel, Ph.D., Regarding Validity of U.S. Patent No. 10,039,718 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/10/2023) (6)
Aug 10, 2023 150 NOTICE OF SERVICE of the [CONFIDENTIAL] Expert Report of Dr. Chloe Lynne Thio, M.D. Regarding the Validity of U.S. Patent No. 10,786,518, the [CONFIDENTIAL] Expert Report of Graham Buckton, Ph.D., D.Sc. Regarding the Enablement of Prior Art to U.S. Patent No. 10,786,518, and the [CONFIDENTIAL] Expert report of Graham Buckton, Ph.D., Sc. Regarding the Validity of U.S. Patent No. 10,039,718 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/10/2023) (2)
Aug 3, 2023 148 NOTICE to Take Deposition of Pramod Dahibhate on August 6, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/03/2023) (5)
Jul 31, 2023 146 NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's Third Set of Requests (Nos. 105-122) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) Modified on 8/1/2023 (vfm). (Main Document 146 replaced on 8/1/2023) (vfm). (Entered: 07/31/2023) (2)
Jul 31, 2023 147 NOTICE OF SERVICE of (1) Apotex's responses to Plaintiffs' First Set of Interrogatories (Nos. 1, 3 and 7-19); (2) Apotex's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-3, 8, 9, 14, 15, 17, 26, 27, 29, 30, 37-41); and (3) Apotex's responses to Plaintiffs' First Set of Requests for Admission (Nos. 3-10) filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 07/31/2023) (3)
Jul 25, 2023 145 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Second Supplemental Response to Plaintiffs' Interrogatories (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 07/25/2023) (2)
Jul 21, 2023 144 NOTICE OF SERVICE of Defendant Apotex Corp.'s Objections and Responses to Plaintiffs' Notice of Subpoena filed by Apotex Corp..(Dorsney, Kenneth) (Entered: 07/21/2023) (3)
Jul 20, 2023 143 NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' Supplemental Notice of Deposition to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) (Topics 1-31) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 07/20/2023) (2)
Jul 7, 2023 140 NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.s [CONFIDENTIAL] Invalidity Contentions and Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland Uc, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Companys Second Set of Requests (Nos. 84-104) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 07/07/2023) (2)
Jul 7, 2023 141 NOTICE OF SERVICE of Defendants [CONFIDENTIAL] Invalidity Contentions Regarding U.S. Patent No. 10,039,718 (the 718 Patent) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 07/07/2023) (2)
Jul 7, 2023 142 NOTICE OF SERVICE of Reference Documents in Support of Defendants' Joint Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) (Entered: 07/07/2023) (3)
Jul 5, 2023 139 NOTICE of Change of Address for Hannah Lee by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 07/05/2023) (5)
Jul 3, 2023 138 ANSWER to 124 Answer to Complaint,, Counterclaim, --Plaintiffs' Answer to Lupin Limited's Counterclaims-- by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 07/03/2023) (10)
Jun 30, 2023 130 NOTICE to Take Deposition of Rajiv Khurana on July 19, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5)
Jun 30, 2023 131 NOTICE to Take Deposition of Jason Gensburger on July 28, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5)
Jun 30, 2023 132 NOTICE to Take Deposition of Dr. Kiran Krishnan on July 17, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5)
Jun 30, 2023 133 NOTICE to Take Deposition of Navin Vaya on July 18, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5)
Jun 30, 2023 134 NOTICE to Take Deposition of Apotex Inc. and Apotex Corp. on July 19, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (13)
Jun 30, 2023 135 NOTICE of Subpoena to Apotex Corp. by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 06/30/2023) (23)
Jun 30, 2023 136 NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Interrogatories (Nos. 1-19) to Apotex Inc. and Apotex Corp.; (2) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-46) for the Production of Documents and Things to Apotex Inc. and Apotex Corp.; and (3) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests for Admission (Nos. 1-13) to Apotex Inc. and Apotex Corp. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (6)
Jun 30, 2023 137 NOTICE OF SERVICE of (1) Plaintiffs' Third Set of Requests (Nos. 105-122) to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. for the Production of Documents and Things and (2) Plaintiffs' Supplemental Notice of Deposition to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5)
Jun 29, 2023 129 MOTION for Pro Hac Vice Appearance of Attorney Daniel Williams - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/29/2023) (5)
Jun 26, 2023 127 STIPULATION and [Proposed] Order to Consolidate by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/26/2023) (5)
Jun 26, 2023 128 SO ORDERED re (127 in 1:21-cv-01621-MN, 37 in 1:22-cv-01399-MN) Stipulation and Order to Consolidate. Signed by Judge Maryellen Noreika on 6/26/2023. SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS (dlw) (Entered: 06/26/2023) (5)
Jun 22, 2023 126 STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims (D.I. 124) to July 6, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/22/2023) (2)
Jun 7, 2023 125 NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Second Set of Requests (Nos. 84-104) for the Production of Documents and Things filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/07/2023) (4)
Jun 1, 2023 124 ANSWER to Complaint filed in 23-508-MN (D.I. 1), Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MSN Laboratories Private Ltd., Lupin Limited, MSN Life Sciences Private Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. (Phillips, John) Modified on 6/2/2023 (dlw). (Entered: 06/01/2023) (30)
May 22, 2023 123 [SEALED] SO ORDERED re (7 in 1:23-cv-00508-MN, 122 in 1:21-cv-01621-MN) Stipulation and Order to Consolidate (Set/Reset Scheduling Order Deadlines - Fact Discovery completed by 7/31/2023. Opening Expert Reports due by 8/10/2023. Rebuttal Expert Reports due by 10/5/2023. Reply Expert Reports due by 11/9/2023. Expert Discovery due by 12/22/2023. Daubert Motions due by 1/5/2024. A Pretrial Conference is set for 5/6/2024 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 5/13/2024 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 5/22/2023. This order has been emailed to local counsel. (dlw) (Entered: 05/22/2023) (0)
May 19, 2023 122 [SEALED] STIPULATION and [Proposed] Order to Consolidate by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) Modified on 5/19/2023 (dlw). (Main Document 122 replaced on 5/19/2023) (dlw). (Entered: 05/19/2023) (0)
May 4, 2023 120 STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 05/04/2023) (2)
May 4, 2023 121 NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Supplemental Rule 26 Disclosures and (2) Plaintiffs' Second Supplemental Response to Defendants' Interrogatory (No. 1) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 05/04/2023) (4)
May 3, 2023 118 STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 05/03/2023) (2)
May 3, 2023 119 ORAL ORDER re 118 STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - IT IS HEREBY ORDERED that the stipulation is DENIED with leave to renew for failure to comply with Rule 16.4 of the Local Rules of Civil Practice and Procedure of the United States District Court for the District of Delaware. ORDERED by Judge Maryellen Noreika on 5/3/2023. (dlw) (Entered: 05/03/2023) (0)
Apr 21, 2023 117 STIPULATION TO EXTEND TIME for: (1) Rebuttal Expert Report Deadline to May 8, 2023 and (2) Reply Expert Report Deadline to June 19, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/21/2023) (2)
Apr 17, 2023 116 NOTICE requesting Clerk to remove Andrew M. Morrell as co-counsel. Reason for request: no longer affiliated with the case. (Bilson, David) (Entered: 04/17/2023) (2)
Mar 13, 2023 115 NOTICE OF SERVICE of the [CONFIDENTIAL] Expert Report of Graham Buckton, Ph.D. and the [HIGHLY CONFIDENTIAL] Expert Report of Chloe Thio, M.D. filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 03/13/2023) (2)
Mar 10, 2023 114 NOTICE OF SERVICE of Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 03/10/2023) (4)
Feb 27, 2023 113 MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Aryeh N. Feinstein)(Bilson, David) (Entered: 02/27/2023) (Main Document) (2)
Feb 27, 2023 113 MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Aryeh N. Feinstein)(Bilson, David) (Entered: 02/27/2023) (Certification of Aryeh N. Feinstein) (1)
Feb 24, 2023 111 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 4-23) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 02/24/2023) (2)
Feb 24, 2023 112 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatory (No. 7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/24/2023) (4)
Feb 23, 2023 110 NOTICE to Take Deposition of Rajeshwar Reddy Sagyam on March 2, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/23/2023) (4)
Feb 21, 2023 109 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (2, 5-7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/21/2023) (4)
Feb 16, 2023 108 MOTION for Pro Hac Vice Appearance of Attorney Marcus A. Colucci - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 02/16/2023) (4)
Feb 15, 2023 107 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (6-7, 10) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/15/2023) (4)
Feb 6, 2023 105 NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' Third Set of Interrogatories (15-16) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Ying, Jennifer) (Entered: 02/06/2023) (4)
Feb 6, 2023 106 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-25) and Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 4-23) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 02/06/2023) (2)
Feb 2, 2023 104 NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-25) and (2) Plaintiffs' Responses to Defendants' Second Set of Interrogatories (Nos. 13-14) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/02/2023) (4)
Jan 30, 2023 102 NOTICE OF SERVICE of (1) Plaintiffs' Validity Contentions Regarding the '718 Patent and (2) Plaintiffs' Final Validity Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/30/2023) (4)
Jan 30, 2023 103 NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited and Defendants Lupin Pharmaceuticals, Inc. MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s [CONFIDENTIAL] Non-Infringement Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/30/2023) (2)
Jan 27, 2023 101 STIPULATION TO EXTEND TIME for the parties to serve Final Non-Infringement and Validity Contentions to January 30, 2023, at noon E.T. - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/27/2023) (2)
Jan 25, 2023 100 MOTION for Pro Hac Vice Appearance of Attorney Jared C. Bunker - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jared C. Bunker)(Bilson, David) (Entered: 01/25/2023) (Main Document) (2)
Jan 25, 2023 100 MOTION for Pro Hac Vice Appearance of Attorney Jared C. Bunker - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jared C. Bunker)(Bilson, David) (Entered: 01/25/2023) (Certification of Jared C. Bunker) (1)
Jan 24, 2023 99 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Response to Plaintiffs' Interrogatories (No. 2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/24/2023) (2)
Jan 20, 2023 96 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) (Topics 1-53) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/20/2023) (2)
Jan 20, 2023 97 STIPULATION and [Proposed] Order to Extend Time Regarding Certain Scheduling Order Deadlines by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/20/2023) (2)
Jan 20, 2023 98 SO ORDERED re 97 Stipulation and Order to Extend Time (Set/Reset Scheduling Order Deadlines: Final Non-Infringement/Validity Contentions due 1/27/2023. Fact Discovery completed by 2/24/2023. Opening Expert Reports due by 3/10/2023. Rebuttal Expert Reports due by 4/24/2023. Reply Expert Reports due by 5/29/2023. Expert Discovery due by 7/7/2023). Signed by Judge Maryellen Noreika on 1/20/2023. (dlw) (Entered: 01/20/2023) (2)
Jan 19, 2023 95 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/19/2023) (4)
Jan 13, 2023 94 REDACTED VERSION of 91 Notice to Take Deposition, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/13/2023) (17)
Jan 6, 2023 93 NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Third Set of Interrogatories (Nos. 4-23) to Defendants and (2) Plaintiffs' First Set of Requests for Admission (Nos. 1-25) - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) Modified on 1/6/2023 (dlw). (Entered: 01/06/2023) (4)
Jan 5, 2023 91 [SEALED] NOTICE to Take Deposition of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. on January 24, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/05/2023) (0)
Jan 5, 2023 92 NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Third Set of Interrogatories (Nos. 15-16) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/05/2023) (2)
Jan 4, 2023 83 NOTICE to Take Deposition of Debashis Mohanty on January 23, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 84 NOTICE to Take Deposition of Jason Gensburger on January 25, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 85 NOTICE to Take Deposition of Makrand Avachat on January 30, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 86 NOTICE to Take Deposition of Komati Satyanarayana on January 27, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 87 NOTICE to Take Deposition of Pramod Dahibhate on February 1, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 88 NOTICE to Take Deposition of Rajiv Khurana on February 3, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 89 NOTICE to Take Deposition of Sanjay Wagh on February 6, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 4, 2023 90 NOTICE to Take Deposition of Suneela Prodduturi on February 8, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4)
Jan 3, 2023 82 NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Second Set of Interrogatories (Nos. 13-14) and Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s First Set of Requests for Admission to Plaintiffs (Nos. 1-25) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/03/2023) (2)
Dec 22, 2022 71 NOTICE to Take Deposition of Katia Boven on January 27, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 72 NOTICE to Take Deposition of Sandeep Mathur on January 25, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 73 NOTICE to Take Deposition of Karen Gerry on January 23, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 74 NOTICE to Take Deposition of Goedele de Smedt on February 1, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 75 NOTICE to Take Deposition of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company Under Federal Rule of Civil Procedure 30(b)(6) on a mutually agreed upon date filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (14)
Dec 22, 2022 76 NOTICE to Take Deposition of Richard Yu on February 10, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 77 NOTICE to Take Deposition of Margo Cooper on January 20, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 78 NOTICE to Take Deposition of William Pyrz on February 8, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 79 NOTICE to Take Deposition of Joanna Koziara on February 6, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 80 NOTICE to Take Deposition of Dominiek Henrist on February 3, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 22, 2022 81 NOTICE to Take Deposition of Roel Mertens on January 30, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2)
Dec 16, 2022 70 NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Response to Plaintiffs' Interrogatories (Nos. 1-3) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/16/2022) (2)
Dec 5, 2022 68 NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/05/2022) (4)
Dec 5, 2022 69 NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc's [CONFIDENTIAL] Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 12/05/2022) (2)
Nov 28, 2022 67 STIPULATION TO EXTEND TIME for Contentions to December 5, 2022 and January 20, 2023 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Bilson, David) (Entered: 11/28/2022) (2)
Nov 22, 2022 66 NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (6-7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/22/2022) (4)
Nov 16, 2022 65 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses to Defendants' Interrogatories (1-12) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/16/2022) (4)
Nov 7, 2022 61 SO ORDERED re 59 Stipulation of Infringement and Order. Signed by Judge Maryellen Noreika on 11/7/2022. (dlw) (Entered: 11/07/2022) (6)
Nov 7, 2022 62 AMENDED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718 B2; 10,786,518 B2. U.S. Patent Nos. 8,497,396 B2 and 9,428,473 B2 dismissed from suit pursuant to D.I. 61. (dlw) (Entered: 11/07/2022) (1)
Nov 7, 2022 63 SO ORDERED re 60 Stipulation and Order to Amend Scheduling Order (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 2/10/2023. Opening Expert Reports due by 3/3/2023. Rebuttal Expert Reports due by 4/17/2023. Reply Expert Reports due by 5/22/2023. Expert Discovery due by 6/30/2023). ORDERED by Judge Maryellen Noreika on 11/7/2022. (dlw) (Entered: 11/07/2022) (2)
Nov 7, 2022 64 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Coleman, Ph.D. - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/07/2022) (4)
Nov 4, 2022 59 STIPULATION of Infringement and [Proposed] Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/04/2022) (6)
Nov 4, 2022 60 STIPULATION and [Proposed] Order to Amend Scheduling Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/04/2022) (2)
Oct 3, 2022 58 STIPULATION TO EXTEND TIME for the substantial completion of document production to October 17, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/03/2022) (2)
Sep 21, 2022 57 NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants' Interrogatories Nos. 1, 2, 5, 6 and 11 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 09/21/2022) (3)
Aug 25, 2022 56 MOTION for Pro Hac Vice Appearance of Attorney Darish Huynh - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 08/25/2022) (4)
Aug 22, 2022 55 NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Supplemental Identification of Prior Art References filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Main Document 55 replaced on 8/23/2022) (dlw). (Entered: 08/22/2022) (2)
Aug 19, 2022 53 NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Identification of Intrinsic and Extrinsic Evidence to Oppose Plaintiffs' Proposed Constructions of Disputed Terms filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/19/2022) (2)
Aug 19, 2022 54 NOTICE OF SERVICE of Plaintiffs' Identification of Intrinsic and Extrinsic Evidence to Oppose Defendants Proposed Constructions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/19/2022) (3)
Aug 11, 2022 52 NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Second Set of Interrogatories (No. 3) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/11/2022) (2)
Aug 9, 2022 51 NOTICE OF SERVICE of Defendants Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/09/2022) (2)
Aug 5, 2022 49 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Disclosure of Proposed Claim Terms for Construction filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John)
Aug 5, 2022 50 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Claim Constructions and Supporting Intrinsic and Extrinsic Evidence filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Jul 28, 2022 47 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy)
Jul 28, 2022 48 SO ORDERED (2)
Docket Text: SO ORDERED re [47] STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates. Signed by Judge Maryellen Noreika on 7/28/2022. (dlw)
Jul 15, 2022 45 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Disclosure of Proposed Claim Terms for Construction filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
Jul 15, 2022 46 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's Identification of Terms for Construction filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Jul 12, 2022 44 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Second Set of Interrogatories (No. 3) to Defendants filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Jun 30, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [43] MOTION for Pro Hac Vice Appearance of Attorney Wayne Barsky, David Glandorf and Allyson Parks filed by Gilead Sciences, Inc., Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 6/30/2022. (dlw)
Jun 30, 2022 43 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wayne Barsky, David Glandorf and Allyson Parks - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy)
Jun 22, 2022 42 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-2) and Defendants' Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-83) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
Jun 15, 2022 41 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' First Set of Interrogatories (Nos. 1-12) and (2) Plaintiffs' Objections and Responses to Defendants' Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.'s First Set of Requests for Production (Nos. 1-117) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Jun 8, 2022 40 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.'s [CONFIDENTIAL] Initial Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
May 9, 2022 38 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Interrogatories (Nos. 1-2) to Defendants and (2) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-83) for the Production of Documents and Things filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
May 9, 2022 39 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
May 2, 2022 37 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-117) and First Set of Interrogatories (Nos. 1-12) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
Apr 29, 2022 36 Notice Requesting Removal of Co-Counsel (3)
Docket Text: NOTICE requesting Clerk to remove Filko Prugo and Kelley Chandler and the law firm Ropes & Gray LLP as co-counsel.. (Tigan, Jeremy)
Apr 27, 2022 34 Proposed Order (22)
Docket Text: PROPOSED ORDER // Stipulated Protective Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) Modified on 4/27/2022 (dlw).
Apr 27, 2022 35 Protective Order (22)
Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 4/27/2022. (dlw)
Apr 22, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [33] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 27, 2022. ORDERED by Judge Maryellen Noreika on 4/22/2022. (dlw)
Apr 22, 2022 33 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 27, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John)
Apr 21, 2022 32 Notice (Other) (3)
Docket Text: NOTICE of Change of Firm Affiliation by Gilead Sciences Ireland UC, Gilead Sciences, Inc. (Tigan, Jeremy)
Apr 18, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [29] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 22, 2022. ORDERED by Judge Maryellen Noreika on 4/18/2022. (dlw)
Apr 18, 2022 31 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
Apr 15, 2022 29 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 22, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy)
Apr 15, 2022 30 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraphs 3 and 4(a) of the Delaware Default Standard for Discovery - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Apr 12, 2022 28 Scheduling Order (14)
Docket Text: SCHEDULING ORDER: Joinder of Parties due by 11/18/2022. Amended Pleadings due by 11/18/2022. Fact Discovery completed by 12/19/2022. Opening Expert Reports due by 4/3/2023. Rebuttal Expert Reports due by 5/15/2023. Reply Expert Reports due by 6/12/2023. Expert Discovery due by 7/17/2023. Claim Construction Opening Brief served by 1/6/2023. Claim Construction Answering Brief served by 1/20/2023. Claim Construction Reply Brief served by 2/2/2023. Claim Construction Surreply Brief served by 2/10/2023. Joint Claim Construction Brief filed by 2/13/2023. A Markman Hearing is set for 3/10/2023 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 9/19/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 10/2/2023 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/12/2022. (dlw)
Apr 5, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 15, 2022 filed by Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 4/5/2022. (mdb)
Apr 4, 2022 27 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 15, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy)
Mar 30, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Charlotte C. Jacobsen for Gilead Sciences Ireland UC and Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Mar 28, 2022 26 Proposed Order (14)
Docket Text: Joint PROPOSED ORDER -- Revised [Proposed] Scheduling Order re [22] Oral Order, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy)
Mar 23, 2022 24 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David)
Mar 23, 2022 25 Notice Requesting Removal of Co-Counsel (3)
Docket Text: NOTICE requesting Clerk to remove Jon Tanaka as co-counsel. Reason for request: No longer with firm. (Tigan, Jeremy)
Mar 22, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER re [21] Proposed Scheduling Order - IT IS HEREBY ORDERED that a 5-day bench trial in this matter will be set for 10/2/2023. On or before 3/29/2022, the parties shall submit a revised proposed Scheduling Order based on the 10/2/2023 trial date. ORDERED by Judge Maryellen Noreika on 3/22/2022. (dlw)
Mar 22, 2022 23 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Initial Rule 26 Disclosures filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Mar 15, 2022 21 Main Document (14)
Docket Text: PROPOSED ORDER // Scheduling Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # (1) Letter to the Honorable Maryellen Noreika)(Tigan, Jeremy) Modified on 3/16/2022 (dlw).
Mar 15, 2022 21 Letter to the Honorable Maryellen Noreika (1)
Mar 11, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [20] STIPULATION TO EXTEND TIME to submit a proposed Scheduling Order pursuant to the Court's February 8, 2022 Oral Order (D.I. 19) to March 15, 2022 filed by Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 3/11/2022. (mdb)
Mar 10, 2022 20 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to submit a proposed Scheduling Order pursuant to the Court's February 8, 2022 Oral Order (D.I. 19) to March 15, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy)
Feb 8, 2022 18 Answer to Counterclaim (7)
Docket Text: ANSWER to [15] Answer to Complaint,, Counterclaim, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy)
Feb 8, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiff serves its opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/8/2022. (dlw)
Jan 19, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Andrew E. Morrell for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jan 18, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [17] MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Andrew E. Morrell, Ph.D. filed by MSN Life Sciences Private Ltd., MSN Laboratories Private Ltd., Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 1/18/2022. (dlw)
Jan 18, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney William R. Zimmerman for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jan 18, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jonathan E. Bachand for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Jan 18, 2022 17 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Andrew E. Morrell, Ph.D. - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of William Zimmerman, # (2) Certification of Jonathan E. Bachand, # (3) Certification of Andrew E. Morrell, Ph.D.)(Bilson, David)
Jan 18, 2022 17 Certification of William Zimmerman (1)
Jan 18, 2022 17 Certification of Jonathan E. Bachand (1)
Jan 18, 2022 17 Certification of Andrew E. Morrell, Ph.D. (1)
Jan 17, 2022 15 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Lupin Pharmaceuticals, Inc., Lupin Limited, MSN Life Sciences Private Ltd. (Phillips, John) Modified on 1/18/2022 (dlw).
Jan 17, 2022 16 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Ltd. for MSN Pharmaceuticals Inc.; Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John)
Dec 21, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [14] MOTION for Pro Hac Vice Appearance of Attorney Charlotte Jacobsen, Filko Prugo, Jon T. Tanaka and Kelley Chandler filed by Gilead Sciences, Inc., Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 12/21/2021. (dlw)
Dec 21, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Charlotte C. Jacobsen and Jon T. Tanaka for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01621-MN, 1:21-cv-01615-MN(srs)
Dec 21, 2021 14 Motion for Leave to Appear Pro Hac Vice (7)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charlotte Jacobsen, Filko Prugo, Jon T. Tanaka and Kelley Chandler - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy)
Dec 17, 2021 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: D.I. 13 has been replaced on the docket at the request of counsel. (dlw)
Dec 17, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [13] MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman, Jonathan Pepin, and Hannah Lee filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. ORDERED by Judge Maryellen Noreika on 12/17/2021. (dlw)
Dec 17, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Hannah Lee, Jonathan R. Pepin, and Irena Royzman for Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 16, 2021 13 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman, Jonathan Pepin, and Hannah Lee - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Main Document 13 replaced on 12/17/2021) (dlw).
Dec 15, 2021 12 SO ORDERED (2)
Docket Text: SO ORDERED re [11] STIPULATION TO EXTEND TIME for MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc. to answer, move, or otherwise respond to the Complaint to January 17, 2022 (Set/Reset Answer Deadlines: MSN Laboratories Private Ltd. answer due 1/17/2022; MSN Life Sciences Private Ltd. answer due 1/17/2022; MSN Pharmaceuticals Inc. answer due 1/17/2022). ORDERED by Judge Maryellen Noreika on 12/15/2021. (dlw)
Dec 14, 2021 11 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc. to answer, move, or otherwise respond to the Complaint to January 17, 2022 - filed by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John)
Nov 24, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
Nov 23, 2021 10 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.. MSN Pharmaceuticals Inc. served on 11/23/2021, answer due 12/14/2021. (Tigan, Jeremy)
Nov 22, 2021 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.: For Lupin Limited waiver sent on 11/18/2021, answer due 1/17/2022. (Tigan, Jeremy)
Nov 22, 2021 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.: For Lupin Pharmaceuticals, Inc. waiver sent on 11/18/2021, answer due 1/17/2022. (Tigan, Jeremy)
Nov 18, 2021 7 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company filed by Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company. (nmg)
Nov 17, 2021 6 Main Document (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 11/17/2021; Lupin Pharmaceuticals, Inc. on 11/17/2021; MSN Laboratories Private Ltd. on 11/17/2021; MSN Life Sciences Private Ltd. on 11/17/2021; MSN Pharmaceuticals Inc. on 11/17/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued)(mal)
Nov 17, 2021 6 Summons Issued (2)
Nov 17, 2021 6 Summons Issued (2)
Nov 17, 2021 6 Summons Issued (2)
Nov 17, 2021 6 Summons Issued (2)
Nov 16, 2021 1 Main Document (32)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3744289.) - filed by Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(mal) . (Main Document 1 replaced on 11/17/2021) (nmg).
Nov 16, 2021 1 Exhibit A-D (134)
Nov 16, 2021 1 Civil Cover Sheet (1)
Nov 16, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
Nov 16, 2021 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/06/2021. Date of Expiration of Patent: U.S. Patent No. 10,039,718 expires on 10/06/2032; U.S. Patent No. 10,786,518 expires on 07/19/2038; and U.S. Patent No. 8,497,396 expires on 10/30/2031; and U.S. Patent No. 9,428,473 expires on 04/01/2030. Thirty Month Stay Deadline: 4/6/2024. (mal)
Nov 16, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,497,396 B2 ;9,428,473 B2 ;10,039,718 B2 ;10,786,518 B2. (mal)
Nov 16, 2021 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Gilead Sciences, Inc. for Gilead Sciences Ireland UC filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (mal)
Nov 16, 2021 1 Complaint* (1)
Menu